Diabetes Prevention Programs (DPPs) are among the most effective tools we have to reduce progression from prediabetes to type 2 diabetes, but only when participants stay engaged. When attendance drops, the clinical “dose” of the intervention shrinks, and the impact you’re counting on (for patients and for your practice) quietly erodes.
Engagement isn’t a soft metric
In the landmark Diabetes Prevention Program trial, an intensive lifestyle intervention reduced the incidence of type 2 diabetes by 58% (vs. placebo), showing what is possible when participants receive and complete structured support. The CDC’s National DPP was created to scale this kind of evidence-based lifestyle change program nationally.
But real-world results depend heavily on participation. In a large participant-level evaluation of the CDC’s National DPP, each additional session attended was associated with greater weight loss, reinforcing that attendance is tightly linked to outcomes. When patients disengage early, you’re no longer delivering the full intervention, so you shouldn’t be expecting full prevention benefits.
The hidden costs providers absorb when engagement is low
1) Preventable progression and more downstream utilization
When DPP engagement is low, patients are more likely to remain on a trajectory toward diabetes, meaning more follow-up visits, intensified medication needs, and earlier complication-risk management. The “cost” is delayed, but it lands back in primary care and chronic disease workflows.
2) Staff time drain and workflow friction
Low engagement increases invisible work: repeated outreach, rescheduling, documenting partial participation, and troubleshooting access barriers. Even if a community partner runs the program, clinics often carry the coordination burden.
3) Weaker value-based performance and program sustainability
For Medicare-aligned prevention efforts, results are tied to real participation. Low engagement can make the program look ineffective when the real issue is incomplete exposure.
What providers can do
- Make referrals “warm,” not passive. Briefly explain that attendance drives outcomes, and help schedule or connect patients immediately.
- Set a clear expectation: “Sessions are the treatment.” Share that benefits are strongest with consistent participation.
- Reduce friction early: Offer format-matched options (virtual, after-hours) and identify barriers by week 2–3 before dropout becomes the default.
- Track engagement like a vital sign: “Attended session 1?” “Active at 4 weeks?”
Bottom line
Low engagement is not just a program problem; it’s a clinical outcomes problem and a business sustainability problem. The evidence is clear that lifestyle-based prevention works, and national systems exist to deliver it. Don’t let low engagement erase the value of your DPP referrals. Start this month by building one simple step into your workflow until it becomes a habit to maintain retention.
References
Centers for Disease Control and Prevention. (2024, May 15). What is the National DPP? National Diabetes Prevention Program.
Ely, E. K., Gruss, S. M., Luman, E. T., Gregg, E. W., Ali, M. K., Nhim, K., Rolka, D. B., & Albright, A. L. (2017). A national effort to prevent type 2 diabetes: Participant-level evaluation of CDC’s National Diabetes Prevention Program. Diabetes Care, 40(10), 1331–1341.
Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346(6), 393–403.